Humacyte, Inc (HUMA)

CIK 1818382 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Humacyte, Inc.

Recent SEC filings

FiledFormAccession number
Oct 7, 202640002156537-26-000004
Oct 7, 202640001247296-26-000005
Sep 28, 202630001247296-26-000003
Sep 28, 202630002156537-26-000002
Sep 28, 20268-K0001818382-26-000011
Sep 15, 202640001193125-26-391889
Aug 25, 202625-NSE0001354457-26-000819
Aug 21, 202640001193125-26-361081
Aug 19, 202640001193125-26-356847
Aug 18, 2026SCHEDULE 13D/A0001104659-26-098152
Aug 12, 20268-K0001104659-26-094440
Aug 12, 202610-Q0001193125-26-347022
Jul 31, 20268-K0001104659-26-089281
Jul 28, 2026SCHEDULE 13G/A0002012383-26-002519
Jul 13, 2026SCHEDULE 13D/A0001104659-26-083164
Jun 22, 2026SCHEDULE 13G0000919574-26-004065
Jun 15, 2026SCHEDULE 13D/A0001104659-26-073827
Jun 12, 202640001104659-26-073614
Jun 12, 202640001104659-26-073617
Jun 12, 202640001104659-26-073613
Jun 12, 202640001104659-26-073607
Jun 12, 202640001104659-26-073620
Jun 12, 202640001104659-26-073608
Jun 12, 202640001104659-26-073616
Jun 12, 202640001104659-26-073610